Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells

被引:2
|
作者
Taylor, Rhonda L. [1 ,2 ]
Cruickshank, Mark N. [3 ]
Karimi, Mahdad [2 ]
Ng, Han Leng [1 ]
Quail, Elizabeth [2 ]
Kaufman, Kenneth M. [4 ,5 ]
Harley, John B. [4 ,5 ]
Abraham, Lawrence J. [1 ]
Tsao, Betty P. [6 ]
Boackle, Susan A. [7 ]
Ulgiati, Daniela [1 ]
机构
[1] Univ Western Australia, Ctr Genet Origins Hlth & Dis, Sch Pathol & Lab Med, Crawley, WA 6009, Australia
[2] Univ Western Australia, Sch Chem & Biochem, Biochem & Mol Biol, Crawley, WA 6009, Australia
[3] Univ Western Australia, Telethon Kids Inst, Crawley, WA 6009, Australia
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[5] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA
[6] Univ Calif Los Angeles, Dept Med, Div Rheumatol, Los Angeles, CA 90024 USA
[7] Univ Colorado, Sch Med, Div Rheumatol, Aurora, CO USA
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
B cells; core promoter; CR2/CD21; molecular biology; transcription factor; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPLEMENT RECEPTOR 2; HUMAN LYMPHOCYTES-B; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; PLASMA-CELL; FACTOR E2A; CR-2; GENE; T-CELLS; C3D;
D O I
10.1038/cmi.2014.138
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement receptor 2 (CR2/CD21) is predominantly expressed on the surface of mature B cells where it forms part of a coreceptor complex that functions, in part, to modulate B-cell receptor signal strength. CR2/CD21 expression is tightly regulated throughout B-cell development such that CR2/CD21 cannot be detected on pre-B or terminally differentiated plasma cells. CR2/CD21 expression is upregulated at B-cell maturation and can be induced by IL-4 and CD40 signaling pathways. We have previously characterized elements in the proximal promoter and first intron of CR2/CD21 that are involved in regulating basal and tissue-specific expression. We now extend these analyses to the CR2/CD21 core promoter. We show that in mature B cells, CR2/CD21 transcription proceeds from a focused TSS regulated by a non-consensus TATA box, an initiator element and a downstream promoter element. Furthermore, occupancy of the general transcriptional machinery in pre-B versus mature B-cell lines correlate with CR2/CD21 expression level and indicate that promoter accessibility must switch from inactive to active during the transitional B-cell window.
引用
收藏
页码:119 / 131
页数:13
相关论文
共 49 条
  • [21] Differential effects on HIV-1 gene regulation by EBV in T lymphocytic and promonocytic cells transduced to express recombinant human CR2 (CD21)
    Romano, G
    Guan, MX
    Long, WK
    Henderson, EE
    VIROLOGY, 1997, 237 (01) : 23 - 32
  • [22] Lymphocytes shed a soluble form of human CD21 (the C3dg/EBV receptor, CR2) that binds iC3b and CD23.
    FremeauxBacchi, V
    Bernard, J
    Maillet, F
    Mani, JC
    Fontaine, M
    Bonnefoy, JY
    Kazatchkine, MD
    Fischer, E
    FASEB JOURNAL, 1996, 10 (06): : 2502 - 2502
  • [23] Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3
    Twohig, Jason
    Kulik, Liudmila
    Haluszczak, Catherine
    Reuter, Jason
    Rossbach, Andreas
    Bull, Melanie
    Holers, V. Michael
    Marchbank, Kevin J.
    MOLECULAR IMMUNOLOGY, 2007, 44 (13) : 3434 - 3444
  • [24] The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2)
    Mongini, PKA
    Vilensky, MA
    Highet, PF
    Inman, JK
    JOURNAL OF IMMUNOLOGY, 1997, 159 (08): : 3782 - 3791
  • [25] Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development (vol 37, pg 1149, 2007)
    Kulik, Liudmila
    Marchbank, Kevin J.
    Lyubchenko, Taras
    Kuhn, Kristine A.
    Liubehenko, Ganna A.
    Haluszczak, Catherine
    Gipson, Matthew G.
    Boackle, Susan A.
    Holers, V. Michael
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (04) : 1149 - 1149
  • [26] The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells
    Nielsen, CH
    Pedersen, ML
    Marquart, HV
    Prodinger, WM
    Leslie, RGQ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (05) : 1359 - 1367
  • [27] Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia
    Marchbank, KJ
    Kulik, L
    Gipson, MG
    Morgan, BP
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 2002, 169 (07): : 3526 - 3535
  • [28] Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes
    Leslie, RGQ
    Prodinger, WM
    Nielsen, CH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (12) : 3311 - 3321
  • [29] Co-operation between human CR1 (CD35) and CR2 (CD21) in internalisation of their ligands (C3b and IC3b) by murine transfected fibroblasts.
    Grattone, ML
    Villiers, CL
    Villiers, MB
    Drouet, C
    Marche, PN
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 407 - 407
  • [30] Co-operation between human CR1 (CD35) and CR2 (CD21) in internalization of their C3b and iC3b ligands by murine-transfected fibroblasts
    Grattone, ML
    Villiers, CL
    Villiers, MB
    Drouet, C
    Marche, PN
    IMMUNOLOGY, 1999, 98 (01) : 152 - 157